Literature DB >> 25863300

Neighborhood deprivation and warfarin, aspirin and statin prescription - A cohort study of men and women treated for atrial fibrillation in Swedish primary care.

Axel C Carlsson1, Per Wändell2, Danijela Gasevic3, Jan Sundquist4, Kristina Sundquist4.   

Abstract

BACKGROUND: We aimed to study differences in the prescribing of warfarin, aspirin and statins to patients with atrial fibrillation (AF) in socio-economically diverse neighborhoods. We also aimed to explore the effects of neighborhood deprivation on the relationship between CHADS2 risk score and warfarin prescription.
METHODS: Data were obtained from primary health care records that contained individual clinical data that were linked to national data on neighborhood of residence and a deprivation index for different neighborhoods. Logistic regression was used to estimate the potential neighborhood differences in prescribed warfarin, aspirin and statins, and the association between the CHADS2 score and prescribed warfarin treatment, in neighborhoods with high, middle (referent) and low socio-economic (SES).
RESULTS: After adjustment for age, socio-economic factors, co-morbidities and moves to neighborhoods with different SES during follow-up, adults with AF living in high SES neighborhoods were more often prescribed warfarin (men odds ratio (OR) (95% confidence interval (CI): 1.44 (1.27-1.62); and women OR (95% CI): 1.19 (1.05-1.36)) and statins (men OR (95% CI): 1.23 (1.07-1.41); women OR (95% CI): 1.23 (1.05-1.44)) compared to their counterparts residing in middle SES. Prescription of aspirin was lower in men from high SES neighborhoods (OR (95% CI): 0.75 (0.65-0.86)) than in those from middle SES neighborhoods. Higher CHADS2 risk scores were associated with higher warfarin prescription which remained after adjustment for neighborhood SES.
CONCLUSIONS: The apparent inequalities in pharmacotherapy seen in the present study call for resource allocation to primary care in neighborhoods with low and middle socio-economic status.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; CHADS2; Cardiovascular epidemiology; Neighborhood; Pharmacotherapy; Socio-economic status; Sweden; Warfarin

Mesh:

Substances:

Year:  2015        PMID: 25863300      PMCID: PMC4442047          DOI: 10.1016/j.ijcard.2015.04.005

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  40 in total

1.  Strategies for early stroke recovery: what lies ahead?

Authors:  Tomoko Kitago; Randolph S Marshall
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-01

2.  Uncontrolled hypertension: beyond pharmacological treatment.

Authors:  Eduardo Pimenta; Michael Stowasser
Journal:  Hypertens Res       Date:  2009-07-17       Impact factor: 3.872

3.  Total mortality among levothyroxine-treated women with atrial fibrillation in Swedish primary health care.

Authors:  Per E Wändell; Axel C Carlsson; Kristina Sundquist; Sven-Erik Johansson; Jan Sundquist
Journal:  Int J Cardiol       Date:  2011-08-17       Impact factor: 4.164

4.  Differences and time trends in drug treatment of atrial fibrillation in men and women and doctors' adherence to warfarin therapy recommendations: a Swedish study of prescribed drugs in primary care in 2002 and 2007.

Authors:  Axel C Carlsson; Per Wändell; Kristina Sundquist; Sven-Erik Johansson; Jan Sundquist
Journal:  Eur J Clin Pharmacol       Date:  2012-06-10       Impact factor: 2.953

5.  Implications of stroke risk criteria on the anticoagulation decision in nonvalvular atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study.

Authors:  A S Go; E M Hylek; K A Phillips; L H Borowsky; L E Henault; Y Chang; J V Selby; D E Singer
Journal:  Circulation       Date:  2000-07-04       Impact factor: 29.690

6.  Coronary heart disease risks in first- and second-generation immigrants in Sweden: a follow-up study.

Authors:  K Sundquist; X Li
Journal:  J Intern Med       Date:  2006-04       Impact factor: 8.989

7.  Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study.

Authors:  S Stewart; C L Hart; D J Hole; J J McMurray
Journal:  Heart       Date:  2001-11       Impact factor: 5.994

8.  Survival after stroke--the impact of CHADS2 score and atrial fibrillation.

Authors:  Karin M Henriksson; Bahman Farahmand; Saga Johansson; Signild Asberg; Andreas Terént; Nils Edvardsson
Journal:  Int J Cardiol       Date:  2009-01-13       Impact factor: 4.164

Review 9.  Lipid-altering therapy and atrial fibrillation.

Authors:  Justin M Bachmann; Maulik Majmudar; Christine Tompkins; Roger S Blumenthal; Joseph E Marine
Journal:  Cardiol Rev       Date:  2008 Jul-Aug       Impact factor: 2.644

10.  Effects of prescribed antihypertensives and other cardiovascular drugs on mortality in patients with atrial fibrillation and hypertension: a cohort study from Sweden.

Authors:  Axel C Carlsson; Per Wändell; Kristina Sundquist; Sven-Erik Johansson; Jan Sundquist
Journal:  Hypertens Res       Date:  2014-03-06       Impact factor: 3.872

View more
  13 in total

1.  Depression or anxiety and all-cause mortality in adults with atrial fibrillation--A cohort study in Swedish primary care.

Authors:  Per Wändell; Axel C Carlsson; Danijela Gasevic; Lars Wahlström; Jan Sundquist; Kristina Sundquist
Journal:  Ann Med       Date:  2016-01-13       Impact factor: 4.709

2.  Neighbourhood socio-economic status and all-cause mortality in adults with atrial fibrillation: A cohort study of patients treated in primary care in Sweden.

Authors:  Per Wändell; Axel C Carlsson; Danijela Gasevic; Jan Sundquist; Kristina Sundquist
Journal:  Int J Cardiol       Date:  2015-09-21       Impact factor: 4.164

3.  Neighbourhood socioeconomic status and coronary heart disease in individuals between 40 and 50 years.

Authors:  Axel C Carlsson; Xinjun Li; Martin J Holzmann; Per Wändell; Danijela Gasevic; Jan Sundquist; Kristina Sundquist
Journal:  Heart       Date:  2016-02-10       Impact factor: 5.994

4.  Neighborhood socioeconomic status at the age of 40 years and ischemic stroke before the age of 50 years: A nationwide cohort study from Sweden.

Authors:  Axel C Carlsson; Xinjun Li; Martin J Holzmann; Johan Ärnlöv; Per Wändell; Danijela Gasevic; Jan Sundquist; Kristina Sundquist
Journal:  Int J Stroke       Date:  2017-04-07       Impact factor: 5.266

5.  Association of Neighborhood Disadvantage and Anticoagulation for Patients with Atrial Fibrillation in the Veterans Health Administration: the REACH-AF Study.

Authors:  Annie McDermott; Nadejda Kim; Leslie R M Hausmann; Jared W Magnani; Chester B Good; Terrence M A Litam; Maria K Mor; Toluwa D Omole; Walid F Gellad; Michael J Fine; Utibe R Essien
Journal:  J Gen Intern Med       Date:  2022-09-23       Impact factor: 6.473

6.  Warfarin treatment and risk of stroke among primary care patients with atrial fibrillation.

Authors:  Per Wändell; Axel C Carlsson; Martin J Holzmann; Johan Ärnlöv; Sven-Erik Johansson; Jan Sundquist; Kristina Sundquist
Journal:  Scand Cardiovasc J       Date:  2016-08-18       Impact factor: 1.589

7.  Warfarin treatment and risk of myocardial infarction - A cohort study of patients with atrial fibrillation treated in primary health care.

Authors:  Per Wändell; Axel C Carlsson; Martin J Holzmann; Johan Ärnlöv; Sven-Erik Johansson; Jan Sundquist; Kristina Sundquist
Journal:  Int J Cardiol       Date:  2016-07-09       Impact factor: 4.164

8.  Socioeconomic factors and mortality in patients with atrial fibrillation-a cohort study in Swedish primary care.

Authors:  Per Wändell; Axel C Carlsson; Danijela Gasevic; Martin J Holzmann; Johan Ärnlöv; Jan Sundquist; Kristina Sundquist
Journal:  Eur J Public Health       Date:  2018-12-01       Impact factor: 3.367

Review 9.  Social determinants of atrial fibrillation.

Authors:  Utibe R Essien; Jelena Kornej; Amber E Johnson; Lucy B Schulson; Emelia J Benjamin; Jared W Magnani
Journal:  Nat Rev Cardiol       Date:  2021-06-02       Impact factor: 32.419

10.  Association Between Neighborhood-Level Poverty and Incident Atrial Fibrillation: a Retrospective Cohort Study.

Authors:  Utibe R Essien; Megan E McCabe; Kiarri N Kershaw; Quentin R Youmans; Michael J Fine; Clyde W Yancy; Sadiya S Khan
Journal:  J Gen Intern Med       Date:  2021-07-08       Impact factor: 6.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.